MedTrace Logo

AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity

NCT07043153 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-05-13

No results posted yet for this study

Summary

This study aims to evaluate the clinical utility of combining the albumin to globulin ratio (AGR) and the prognostic nutritional index (PNI) as a predictive model for assessing disease activity in patients with systemic lupus erythematosus (SLE). By correlating these nutritional and inflammatory markers with clinical manifestations and laboratory parameters, we hope to establish a simple, non-invasive, and cost-effective tool to aid in monitoring disease activity in Systemic lupus erythematosus patients.

Conditions

  • Systemic Lupus Erythematosus Disease

Interventions

DIAGNOSTIC_TEST

Albumin to globulin ratio and prognostic nutritional index model

Measurement of albumin to globulin ratio and prognostic nutritional index in participants to assess disease activity in systemic lupus erythematosus patients

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Esam M Abualfadl, Professor · Sohag University

  • Rabab H Ali, MD · Sohag University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-05
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07043153 on ClinicalTrials.gov